Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for March 9th

Read MoreHide Full Article

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 9th:

BioCryst Pharmaceuticals, Inc. (BCRX - Free Report) : This biotechnology company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 33.6% over the last 60 days.

BioCryst Pharmaceuticals’ shares gained 38.4% over the last one month above the S&P 500’s decrease of 11.3%. The company possesses a Momentum Score of A.

Kinross Gold Corporation (KGC - Free Report) : This explorer, acquirer and developer of gold properties has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 19% over the last 60 days.

Kinross Gold’s shares gained 11.4% over the last one month. The company possesses a Momentum Score of A.

Livongo Health, Inc. LVGO: This provider of an integrated suite of solutions for the healthcare industry has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 31% over the last 60 days.

Livongo Health’s shares gained 12.6% over the last one month. The company possesses a Momentum Score of A.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

More Stock News: This Is Bigger than the iPhone!                  

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020. 

Click here for the 6 trades >>

 


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Kinross Gold Corporation (KGC) - free report >>

BioCryst Pharmaceuticals, Inc. (BCRX) - free report >>